Market Cap 1.73B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 6,269,300
Avg Vol 7,238,266
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 1%
Beta 1.14
Analysts Strong Sell
Price Target $10.50

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
PLTRLONGDONG
PLTRLONGDONG Jul. 25 at 3:03 AM
$ABCL wheres your proof of the leak… still havent seen it? sit and spin while we run it to $200 in 5 years
0 · Reply
MaryHiggins354
MaryHiggins354 Jul. 24 at 8:24 PM
$ABCL CEO Carl Hansen highlighted the long-term vision around building deep-tech companies that can drive innovation in areas like healthcare, energy, and advanced technology. For AbCellera, the focus remains on turning its discovery platform into meaningful partnerships and future therapies. The opportunity is significant, but execution and real-world results will determine the long-term value.
0 · Reply
AndyJudeHeyward
AndyJudeHeyward Jul. 24 at 7:54 PM
$ABCL SHES DUMPING HAHAHA BALD ASS CEO
1 · Reply
tradersunion353
tradersunion353 Jul. 24 at 7:50 PM
$ABCL every single pumper here deserve this crash clowns have gone mad with restless pumping
0 · Reply
MarketFractal
MarketFractal Jul. 24 at 7:47 PM
$ABCL’s long-term thesis is gaining more validation as pharma partnerships continue to develop. Jazz’s upfront payment and milestone commitments for AbCellera’s T cell engager platform highlight growing interest in its technology for solid tumor programs. The key question now is whether these partnerships can translate into successful clinical outcomes and meaningful revenue over time.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 24 at 7:19 PM
$ABCL The real $ABCL compounding is the data flywheel. Every campaign they run feeds proprietary data back into the platform, which makes the next campaign better. Software economics quietly showing up in biotech. The moat widens with use, not with spend.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 24 at 7:14 PM
$ABCL “If we choose wisely, 20 years from now, we could have global companies—curing cancer, building new energy sources, high-tech, deep-tech businesses that move the country forward.” - Carl Hansen This is our CEO. Deeply invested and aligned with the country’s future 🍀
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 24 at 7:13 PM
$ABCL AI + pathogens = existential risk. Rapid antibody platforms are the counter. Abcellera already built one (DARPA P3 → COVID proof). That’s the real edge. $ABCL
0 · Reply
Ckkung71
Ckkung71 Jul. 24 at 7:02 PM
$ABCL It’s all about the volume. Soon vacation is over .
1 · Reply
PolarBear1
PolarBear1 Jul. 24 at 6:52 PM
$ABCL Never ceases to amaze me how this stock is so heavily manipulated! Absolutely bizarre. I’d be buying more here if I didn’t already have a full position (below $5). To invest in $ABCL right now you really need to believe that the Phase 2 topline (very preliminary) results to be released within the next two months will be positive (that’s what I think). It’s binary - either we go to $10-$12 ish per share in 2026 or we drop below $3 IMHO. In either case the stock will stabilize and then build back towards $40-$60 ps over the next 3-5 years.
1 · Reply
Latest News on ABCL
AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 17 days ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 18 days ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 18 days ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera appoints Victor Sandor to board of directors

2026-06-05T13:05:56.000Z - 7 weeks ago

AbCellera appoints Victor Sandor to board of directors


AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 2 months ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 2 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 2 months ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 3 months ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 5 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 5 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 5 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 6 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 9 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 9 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 9 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 11 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


PLTRLONGDONG
PLTRLONGDONG Jul. 25 at 3:03 AM
$ABCL wheres your proof of the leak… still havent seen it? sit and spin while we run it to $200 in 5 years
0 · Reply
MaryHiggins354
MaryHiggins354 Jul. 24 at 8:24 PM
$ABCL CEO Carl Hansen highlighted the long-term vision around building deep-tech companies that can drive innovation in areas like healthcare, energy, and advanced technology. For AbCellera, the focus remains on turning its discovery platform into meaningful partnerships and future therapies. The opportunity is significant, but execution and real-world results will determine the long-term value.
0 · Reply
AndyJudeHeyward
AndyJudeHeyward Jul. 24 at 7:54 PM
$ABCL SHES DUMPING HAHAHA BALD ASS CEO
1 · Reply
tradersunion353
tradersunion353 Jul. 24 at 7:50 PM
$ABCL every single pumper here deserve this crash clowns have gone mad with restless pumping
0 · Reply
MarketFractal
MarketFractal Jul. 24 at 7:47 PM
$ABCL’s long-term thesis is gaining more validation as pharma partnerships continue to develop. Jazz’s upfront payment and milestone commitments for AbCellera’s T cell engager platform highlight growing interest in its technology for solid tumor programs. The key question now is whether these partnerships can translate into successful clinical outcomes and meaningful revenue over time.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 24 at 7:19 PM
$ABCL The real $ABCL compounding is the data flywheel. Every campaign they run feeds proprietary data back into the platform, which makes the next campaign better. Software economics quietly showing up in biotech. The moat widens with use, not with spend.
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 24 at 7:14 PM
$ABCL “If we choose wisely, 20 years from now, we could have global companies—curing cancer, building new energy sources, high-tech, deep-tech businesses that move the country forward.” - Carl Hansen This is our CEO. Deeply invested and aligned with the country’s future 🍀
0 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 24 at 7:13 PM
$ABCL AI + pathogens = existential risk. Rapid antibody platforms are the counter. Abcellera already built one (DARPA P3 → COVID proof). That’s the real edge. $ABCL
0 · Reply
Ckkung71
Ckkung71 Jul. 24 at 7:02 PM
$ABCL It’s all about the volume. Soon vacation is over .
1 · Reply
PolarBear1
PolarBear1 Jul. 24 at 6:52 PM
$ABCL Never ceases to amaze me how this stock is so heavily manipulated! Absolutely bizarre. I’d be buying more here if I didn’t already have a full position (below $5). To invest in $ABCL right now you really need to believe that the Phase 2 topline (very preliminary) results to be released within the next two months will be positive (that’s what I think). It’s binary - either we go to $10-$12 ish per share in 2026 or we drop below $3 IMHO. In either case the stock will stabilize and then build back towards $40-$60 ps over the next 3-5 years.
1 · Reply
blueshirts10
blueshirts10 Jul. 24 at 6:48 PM
$ABCL data coming Monday.
3 · Reply
AndyJudeHeyward
AndyJudeHeyward Jul. 24 at 6:42 PM
$ABCL FUK THIS BALD HEADED PEDO CEO HAHAHA
1 · Reply
Ed_Ng
Ed_Ng Jul. 24 at 6:13 PM
$ABCL lol this scam
0 · Reply
8008track
8008track Jul. 24 at 5:46 PM
$ABCL bought more today
2 · Reply
Stocktradesmoon
Stocktradesmoon Jul. 24 at 5:35 PM
$ABCL This is the $ABCL thesis playing out live. In June a top 20 pharma Jazz paid up front and committed to milestones to use AbCellera's T cell engager platform against solid tumors. You do not sign that check to rent a shovel that does not dig.
1 · Reply
tradersunion353
tradersunion353 Jul. 24 at 5:22 PM
$ABCL if you are a real share holder what you clowns cheerleading and celebrating whenever stovk drops 🤮
0 · Reply
tradersunion353
tradersunion353 Jul. 24 at 3:02 PM
$ABCL everytime this pos drops crazily same pumpers or paper traders become restless with adding and loading, gift comments how silly to see these clowns 🤡
0 · Reply
AndyJudeHeyward
AndyJudeHeyward Jul. 24 at 2:51 PM
$ABCL lol bald clown ceo
2 · Reply
tradersunion353
tradersunion353 Jul. 24 at 2:50 PM
$ABCL clowns pretending that everyone believes in their adding and loading 😂😂😂
0 · Reply
tradersunion353
tradersunion353 Jul. 24 at 2:38 PM
$ABCL paper trader will be a paper trade clowns posting adding and loading will not make this a legit trade
0 · Reply
tradersunion353
tradersunion353 Jul. 24 at 2:38 PM
$ABCL any updates from management on leaked failed or bad ABCL 635 phase 2 data? stock is almost near to 50% loss ever since phase 2 data is leaked
0 · Reply
Stockingtrade
Stockingtrade Jul. 24 at 2:37 PM
$ABCL Just dropped below pre-Jazz price, on no news. I just doubled down with some extra shares - great time to buy!
0 · Reply